Cargando…
AB Toxins as High-Affinity Ligands for Cell Targeting in Cancer Therapy
Conventional targeted therapies for the treatment of cancer have limitations, including the development of acquired resistance. However, novel alternatives have emerged in the form of targeted therapies based on AB toxins. These biotoxins are a diverse group of highly poisonous molecules that show a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343017/ https://www.ncbi.nlm.nih.gov/pubmed/37446406 http://dx.doi.org/10.3390/ijms241311227 |